Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00387491 · ClinicalTrials.gov registry record · Phase 1
Dose Ranging Study in Healthy Methadone Maintenance Subjects
A Phase 1 study of Adult, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT00387491 is a Phase 1 study of Adult that has completed, run by Bausch Health Americas. The registered enrollment target is 16 participants, below the 182-participant average among 10 other Adult trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00387491, a Phase 1 study of Adult, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
To assess the effect of a single oral dose of MOA-728, an investigational drug, on the oral-cecal transit time in subjects who are taking methadone.
Conditions Studied
Interventions
- DRUG MOA-728
Study Locations (1)
Kansas
- - Lenexa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2006-06 |
| Est. Completion | 2006-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00387491
The ClinicalTrials.gov registry entry for NCT00387491 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 182-participant average among 10 other Adult trials with a reported enrollment target (91% lower). The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adult appearing as the primary indexed condition, and to 1 intervention - of which MOA-728 is the first listed.
NCT00387491 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT00387491 about?
NCT00387491 is a clinical study titled "Dose Ranging Study in Healthy Methadone Maintenance Subjects". To assess the effect of a single oral dose of MOA-728, an investigational drug, on the oral-cecal transit time in subjects who are taking methadone.
What is the current status of trial NCT00387491?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2006-06. Estimated completion is 2006-10.
What conditions does trial NCT00387491 study?
This clinical trial studies the following conditions: Adult.
What interventions are being tested in trial NCT00387491?
The interventions under investigation include: MOA-728 (DRUG).
Who is sponsoring clinical trial NCT00387491?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00387491 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic Malignancies
RECRUITING · Phase 1
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Study of New Magnetic Resonance Imaging Methods of the Brain
RECRUITING
-
Peanuts for Cardiometabolic, Brain, and Intestinal Health
RECRUITING · NA
-
The Effects of Endotracheal Suctioning on Pain and Serum Markers
RECRUITING · NA
-
Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.